Fbxw7 hotspot mutations and human colon cancer: Mechanistic insights from new mouse models

Gut

Volumn 63, Issue 5, 2014, Pages 707-709

  Grim, Jonathan E ^a  

^a USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN FBXW7; UNCLASSIFIED DRUG;

CANCER PROGNOSIS; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLON CANCER; DISEASE ASSOCIATION; DNA SEQUENCE; FBXW7 GENE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; HETEROZYGOSITY LOSS; MISSENSE MUTATION; MOUSE; MOUSE MODEL; MUTATOR GENE; NONHUMAN; NONSENSE MUTATION; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASIC SCIENCES; CANCER GENETICS; CELL BIOLOGY; COLON CARCINOGENESIS; COLORECTAL CANCER GENES;

ADENOMATOUS POLYPS; ANIMALS; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; F-BOX PROTEINS; HUMANS; INTESTINAL POLYPS; MUTATION, MISSENSE; TUMOR MARKERS, BIOLOGICAL; UBIQUITIN-PROTEIN LIGASES;

EID: 84897965636     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305144     Document Type: Note

References (10)

1. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007;318:1108-13. (Pubitemid 350134889)
2. Muzny DM, Bainbridge MN, Chang K, et al. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012;487:330-7.
3. Berger AH, Knudson AG, Pandolfi PP. A continuum model for tumour suppression. Nature 2011;476:163-9.
4. Venkatachalam S, Shi YP, Jones SN, et al. Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation. EMBO J 1998;17:4657-67. (Pubitemid 28377166)
5. Alimonti A, Carracedo A, Clohessy JG, et al. Subtle variations in Pten dose determine cancer susceptibility. Nat Genet 2010;42:454-8.
6. Welcker M, Clurman BE. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat Rev Cancer 2008;8:83-93. (Pubitemid 351161321)
7. Kemp Z, Rowan A, Chambers W, et al. CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. Cancer Res 2005;65:11361-6. (Pubitemid 41821693)
8. Davis H, Tomlinson I. CDC4/FBXW7 and the 'just enough' model of tumourigenesis. J Pathol 2012;227:131-5.
9. Davis H, Lewis A, Behrens A, et al. Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines. Gut 2014;63:792-9.
10. Iwatsuki M, Mimori K, Ishii H, et al. Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Int J Cancer 2010;126:1828-37.